Evaluation of Longterm Outcome of New York Heart Association Class III Heart Failure Patients Receiving Telemonitoring Using a Pulmonary Artery Pressure Sensor System (CardioMEMS)

Phase

N/A

Condition

Heart Failure

Congestive Heart Failure

Hyponatremia

Treatment

N/A

Clinical Study ID

NCT03020043

FFM CardioMEMS Registry

Ages 18-85
All Genders

Study Summary

Invasive hemodynamic monitoring in advanced heart failure patients is a relative new option. In order to investigate the impact of remote telemonitoring of pulmonary artery pressures on mortality and morbidity in a routine clinical setting in Germany, the investigators initiated this multicenbtric registry.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Implantation of CardioMEMS successful
Telemonitoring according to the SOP of the Frankfurt Heart Failure Center (GoetheUniversity)

Exclusion

Exclusion Criteria:

Unwillingness to participate in the registry

Study Design

August 01, 2016

December 31, 2025

Study Description

All patients who receive invasive hemodynamic monitoring using a pulmonary artery pressure sensor (CardioMEMS device) are offered participation in the registry. Routine heart-failure parameters, lab values, medication and QoL as obtained on the regular outpatients visits in the department are entered into a registry-specific database.

The investigators plan to asses the impact of telemonitoring on mortality, morbidity and QoL as well as on Guideline-recommended heart failure medication. In addition, it is planned to quantify the input in person time for telemonitoring.

Connect with a study center

Klinikum Goethe University
Frankfurt am Main, 60590
Germany
Active - Recruiting
University Hospital Justus-Liebe University
Gießen, 35392
Germany
Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.